Home         Forums  

Go Back   Marrowforums > Bone Marrow Failure Diseases > News and Events
Register FAQ Search Today's Posts Mark Forums Read

News and Events News related to bone marrow failure diseases

Reply
 
Thread Tools Search this Thread
  #1  
Old Sun Oct 1, 2006, 03:18 AM
Marrowforums Marrowforums is offline
Marrowforums.org
 
Join Date: Jul 2006
Posts: 709
Anti-fungal Inhalation Powder Granted Orphan Drug Status

The FDA has granted orphan drug status to an inhalation powder form of the anti-fungal drug Amphotericin B, to prevent infections in immunosuppressed patients. The new powder was developed by biopharmaceutical company Nektar Therapeutics.

Earlier this year, the inhalation powder was approved by the FDA for use in patients at risk for infections such as aspergillosis. These patients, who may have had chemotherapy, radiation, or transplants for hematologic malignancies, commonly develop fungal infections in their lungs that can spread throughout the body. Inhaling the Amphotericin B powder prior to developing an infection may reduce the incidence of infections as well as the high morbidity and mortality associated with them.

Complete text of Nektar press release
Reply With Quote
Reply


Thread Tools Search this Thread
Search this Thread:

Advanced Search

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

vB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Forum Jump


All times are GMT -4. The time now is 07:31 AM.


Powered by vBulletin® Version 3.6.7
Copyright ©2000 - 2017, Jelsoft Enterprises Ltd.
Forum sites may contain non-authoritative and unverified information.
Medical decisions should be made in consultation with qualified medical professionals.
Site contents exclusive of member posts Copyright 2006-2016 Marrowforums.org